Overview

Safety and Effectiveness of Giving Indinavir and Nelfinavir to HIV-Infected Patients

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if it is safe and effective to treat HIV-infected patients with indinavir (IDV) plus nelfinavir (NFV), 2 anti-HIV medications. It is thought that IDV plus NFV will be a safe drug combination for treating HIV.
Phase:
N/A
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Indinavir
Nelfinavir